# Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis

> **NCT04175392** · PHASE1,PHASE2 · TERMINATED · sponsor: **Corewell Health East** · enrollment: 14 (actual)

## Conditions studied

- Fatty Liver Disease
- Fibrosis, Liver
- Cirrhosis, Liver
- Steatohepatitis, Nonalcoholic

## Interventions

- **DRUG:** Align Probiotic Supplement Capsule
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04175392
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-12
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04175392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04175392, "Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04175392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*